338 results on '"Varaldo, Riccardo"'
Search Results
2. The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
3. Second haploidentical stem cell transplantation for primary graft failure
4. Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
5. Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection
6. Total Marrow Irradiation for Second Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia
7. Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up
8. Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up
9. Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography
10. De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period
11. Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide
12. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor
13. An aggressive form of MOGAD treated with aHSCT: A case report
14. An aggressive form of MOGAD treated with aHSCT: A case report.
15. Haploidentical bone marrow transplantation for AML in remission after TBF conditioning: a long-term follow-up
16. Implications for managerial and industrial policy
17. Diagnosis by liver stiffness measurement of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation: results from the Italian multicentric prospective study (ELASTOVOD)
18. Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation
19. Introduzione
20. Improved Outcome of Alternative Donor Transplantations in Patients with Myelofibrosis: From Unrelated to Haploidentical Family Donors
21. Good tolerability of high dose colistin-based therapy in patients with haematological malignancies
22. Haploidentical Hematopoietic Cell Transplantation for Myelofibrosis in the Ruxolitinib Era
23. Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts
24. Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated with Expansion and Maturation of NK Cells
25. Institutional innovations in industrial districts
26. Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
27. CMV Infection after Transplant from Cord Blood Compared to Other Alternative Donors: The Importance of Donor-Negative CMV Serostatus
28. Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
29. Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation
30. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
31. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia
32. Epidemiology of viral respiratory tract infections in an outpatient haematology facility
33. The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases
34. Public Support to Export Consortia: The Italian Case
35. Hematologic Recovery after Allogeneic Transplantation: Risk Factors and Its IMPACT on Transplant Related Mortality
36. Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells
37. Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment
38. The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin’s lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience
39. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
40. Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Truly Refractory Hodgkin Lymphoma Patients Is Highly Effective and Responses Are Mediated By NK Cells
41. Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis
42. OS-124-YI - Diagnosis by liver stiffness measurement of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation: results from the Italian multicentric prospective study (ELASTOVOD)
43. Nuovi modelli di business e creazione di valore: la Scienza dei Servizi
44. Human capital, innovation and competitiveness in Italian industry
45. Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expression
46. Second haploidentical stem cell transplantation for primary graft failure
47. Total Marrow Irradiation for Second Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia
48. Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases
49. Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab
50. Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.